Drug Developer Acelyrin Raises $540 Million in IPO
Wall Street Journal
Biotech company had collected more than $550 million in venture capital.
https://www.wsj.com/articles/drug-developer-acelyrin-raises-540-million-in-ipo-2c2c1a40
Understanding current events through the lenses of the past and future.
Wall Street Journal
Biotech company had collected more than $550 million in venture capital.
https://www.wsj.com/articles/drug-developer-acelyrin-raises-540-million-in-ipo-2c2c1a40